Follow

Submissions from 2024

Pharmacodynamics and Gene Expression Analysis of Patients with Renal Cell Carcinoma Treated with Combination Nivolumab and TPST-1120 in a Phase I Clinical Trial (NCT03829436), Bruno Bastos

Phase I Study of Elraglusib (9-ING-41), a Glycogen Synthase Kinase-3β Inhibitor, as Monotherapy or Combined with Chemotherapy in Patients with Advanced Malignancies, Bruno Bastos

Impact of TP53, RB1, and PTEN Mutations on Overall Survival in Metastatic Prostate Cancer: A Multi-center Study Via the Guardian Research Network., Mohammad Ganiyani, Pushan Prabhakar, Atulya Khosla, Shreyas Bellur, Arjun Avudaiappan, Bruno Bastos, and Rohan Garje

Low contralateral failure rate with unilateral proton beam radiotherapy for oropharyngeal squamous cell carcinoma: A multi-institutional prospective study from the proton collaborative group, Noah Kalman and Robert Press

PDF

Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma: Meta-Analysis and International Stereotactic Radiosurgery Society Practice Guidelines, Rupesh Kotecha

PDF

Accelerated Hypofractionated Magnetic Resonance Guided Adaptive Radiation Therapy for Ultracentral Lung Tumors, Alonso La Rosa de los Rios, Kathryn Mittauer, Nema Bassiri-Gharb, Amy Rzepczynski, Michael Chuong, Sreenija Yarlagadda, Tugce Kutuk, Nicole McAllister, Matthew Hall, Alonso Gutierrez, Ranjini Tolakanahalli, Minesh Mehta, and Rupesh Kotecha

PDF

Intraductal papillary neoplasms of the bile ducts: a comparative study of a rare disease in Europe and Nagoya, Japan, Nuria Lluis Vinas and Horacio Asbun

PDF

Commissioning Intracranial Stereotactic Radiosurgery for a Magnetic Resonance-Guided Radiation Therapy (MRgRT) System: MR-RT Localization and Dosimetric End-to-End Validation, Kathryn Mittauer, Ranjini Tolakanahalli, Rupesh Kotecha, Michael Chuong, Minesh Mehta, Alonso Gutierrez, and Nema Bassiri-Gharb

Submissions from 2023

Tucatinib, Trastuzumab, and Capecitabine with Stereotactic Radiosurgery in Patients with Brain Metastases from Her-2 Positive Breast Cancer (TUTOR): A Multicenter Phase 1 Clinical Trial, Manmeet Ahluwalia, Atulya Khosla, Ahmad Ozair, Rupesh Kotecha, Michael McDermott, Minesh Mehta, Ana Sandoval Leon, and Reshma Mahtani

Prophylactic Cranial Irradiation in Small Cell Lung Cancer Patients in the Era of Magnetic Resonance Imaging: A Systematic Review and Meta-analysis, Manmeet Ahluwalia and Minesh Mehta

A Randomized Phase 2b Study of Surviving Vaccine Survaxm Plus Adjuvant Temozolomide For Newly-Diagnosed Glioblastoma (SURVIVE), Manmeet Ahluwalia, Yazmin Odia, Ahmad Ozair, and Atulya Khosla

Evaluating the Diagnostic Performance of Leptomeningeal Diagnosis with CNSide™ Compared to Standard Cytology, Haley Appel, Anshul Saxena PhD, Rupesh Kotecha, Alexander Mohler, Matthew Hall, Manmeet Ahluwalia, Minesh Mehta, Yazmin Odia, and Serguei Castaneda

PDF

Eleven-Year Experience with Selective Adrenal Vein Sampling in Management of Primary Adrenal Hormonal Hypersecretion, Domenech Asbun and Horacio Asbun

SAGES safe cholecystectomy modules improve practicing surgeons' judgment: results of a randomized, controlled trial, Horacio Asbun

Commissioning Intracranial Stereotactic Radiosurgery (SRS) for an MR-GuidedRadiotherapy (MRgRT) System: MR-RT Localization and Dosimetric End-to-End Validation, Nema Bassiri-Gharb, Ranjini Tolakanahalli, Rupesh Kotecha, Michael Chuong, Minesh Mehta, Alonso Gutierrez, and Kathryn Mittauer

BPI23-011: Real-World Study of First-Line Treatment Patterns in HR+/HER2– Metastatic Breast Cancer (MBC) at a Tertiary Care Cancer Institute, Yolcar Chamorro, Manmeet Ahluwalia, Muni Rubens, Reshma Mahtani, and Ana Sandoval Leon

Outcomes among Hispanic metastatic breast cancer patients treated with alpelisib and fulvestrant: single institution retrospective study, Yolcar Chamorro, Reshma Mahtani, Shanada Monestime, Naomi Dempsey, Muni Rubens, Manmeet Ahluwalia, and Ana Sandoval Leon

Incidence and outcomes among patients with HR+/HER2- metastatic breast cancer (mBC) with co-occurring ESR1 and PIK3CA mutations detected by ctDNA and treated with alpelisib: A retrospective review., Yolcar Chamorro, Ana Sandoval Leon, Manmeet Ahluwalia, Reshma Mahtani, and Naomi Dempsey

"Good-Catches Inventory to Interactive Data-Repository: Management and Analysis for Process Improvement", Vibha Chaswal, Cecilia Lee, D Jay Wieczorek, Alonso Gutierrez, and Ranjini Tolakanahalli

PDF

Advances in MRI-Guided Radiation Therapy, Michael Chuong

PDF

Hits and Misses in Novel Pancreatic and Rectal Cancer Treatment Options, Michael Chuong

PDF

Neoadjuvant chemotherapy and stereotactic body radiation therapy for borderline resectable pancreas adenocarcinoma: influence of vascular margin status and type of chemotherapy, Michael Chuong

Treatment of Thymoma and Thymic Carcinoma with Proton Beam Therapy: Long-term Outcomes from the Proton Collaborative Group Registry, Michael Chuong

Prognostic value of neutrophil/lymphocyte count in pancreas patients receiving ablative MR-guided RT, Michael Chuong, Robert Herrera, Muni Rubens, Antonio Ucar, Fernando De Zarraga, Santiago Aparo, Sarah Joseph, Matthew Hall, Rupesh Kotecha, Adeel Kaiser, and Gigi Estevez

Ablative 5-fraction CT- versus MR-guided pancreatic SBRT: dosimetric effects of interfraction anatomic change, Michael Chuong, Adeel Kaiser, Matthew Hall, Rupesh Kotecha, Diane Alvarez, Nema Bassiri-Gharb, Alonso Gutierrez, James McCulloch, Kathryn Mittauer, Nicole McAllister, Ashley Fellows, Amy Rzepczynski, and Will Deere

Patterns of locoregional failure after ablative 5-fraction stereotactic MR-guided on-table adaptive radiation therapy for pancreatic cancer, Michael Chuong, Nicole McAllister, Surya Chundru, Robert Herrera, Adeel Kaiser, Matthew Hall, Rupesh Kotecha, Kathryn Mittauer, Diane Alvarez, James McCulloch, Nema Bassiri-Gharb, Alonso Gutierrez, Nicolas Carvallo, and Jason Extein

Phase II Trial of Stereotactic MR-guided On-table Adaptive Radiation Therapy for Borderline or Locally Advanced Pacreatic Cancer: Updated Safety & Efficacy Outcomes, Michael Chuong and Kathryn Mittauer

Quality of life after ablative 5-fraction radiation therapy from the phase II SMART pancreas trial, Michael Chuong and Kathryn Mittauer

Phase II trial of single-fraction SABR on 0.35T MRI-linac for thoracic, abdominal, and pelvic tumors, Michael Chuong, Kathryn Mittauer, Martin Tom, Noah Kalman, James McCulloch, Diane Alvarez, Paul Kaywin, Antonio Ucar, Federico Albrecht, Fernando De Zarraga, Santiago Aparo, Guilherme Rabinowits, Muni Rubens, Alonso Gutierrez, Rupesh Kotecha, and Carolina Rojas

Prospective Study Phase II Trial of Stereotactic MRI-Guided Adaptive Radiotherapy in 1 Fraction: Unplanned Interim Analysis, Michael Chuong, Kathryn Mittauer, Martin Tom, Noah Kalman, James McCulloch, Diane Alvarez, Paul Kaywin, Antonio Ucar, Federico Albrecht, Fernando De Zarraga, Santiago Aparo, Muni Rubens, Alonso Gutierrez, and Rupesh Kotecha

Multi-institutional outcomes of proton beam therapy for hepatocellular carcinoma from the Proton Collaborative Group REG001-09 stud, Michael Chuong and Muni Rubens

PDF

Characterization of Physical Function and Cancer-Related Physical Impairments in Hispanic Women With Breast Cancer: A Descriptive Study, Adrian Cristian, Muni Rubens, Grace Wang, and Jane Mendez

Metastatic HER2‑Positive Breast Cancer: Is There an Optimal Sequence of Therapy?, Naomi Dempsey, Ana Sandoval Leon, and Reshma Mahtani

Proton craniospinal irradiation for patients with solid tumor leptomeningeal metastasis: Suggested planning approaches for prior irradiation patients, Zachary Fellows, Andrew Wroe, Rupesh Kotecha, Matthew Hall, Minesh Mehta, and Alonso Gutierrez

PDF

Variable Relative Biological Effectiveness of Proton Therapy Increases PET-Visible Mucosal Injury in Head and Neck Cancer Patients, Edgar Gelover Reyes, Raees Tonse, Surya Chundru, Adeel Kaiser, Len Coutinho, Ryan Zielan, Zachary Fellows, and Noah Kalman

Dose-escalated proton therapy with concurrent and adjuvant immunotherapy for chordoma: early results and toxicities from a single institution case series, Matthew Hall

Multi-institutional experience of proton therapy for osteosarcoma in the Proton Collaborative Group (PCG) prospective registry, Matthew Hall, Keitrina Mair, and Katherine Von Werne

Dose-escalated proton therapy with concurrent and adjuvant immunotherapy for chordoma: Early results and toxicities from a single institution case series ​, Matthew Hall, Yazmin Odia, Minesh Mehta, Muni Rubens, Ranjini Tolakanahalli, Alonso Gutierrez, Keitrina Mair, Katherine Von Werne, and Carlos Rios

The A3i System Significantly Reduces Treatment Times for MRLinac Radiotherapy, Robert Herrera, Michael Chuong, Kathryn Mittauer, James McCulloch, Diane Alvarez, Nema Bassiri-Gharb, Ranjini Tolakanahalli, Adeel Kaiser, Matthew Hall, Rupesh Kotecha, Minesh Mehta, and Alonso Gutierrez

Dosimetric Comparison of GammaTile Implants to Stereotactic Radiotherap, Robert Herrera, Rupesh Kotecha, Tugce Kutuk, D Jay Wieczorek, Vibha Chaswal, Michael McDermott, Vitaly Siomin, Minesh Mehta, Alonso Gutierrez, Ranjini Tolakanahalli, and Zachary Fellows

GammaTile® brachytherapy versus stereotactic radiotherapy: A dosimetric comparison for the treatment of recurrent brain metastasis resection cavities, Robert Herrera, Rupesh Kotecha, Tugce Kutuk, D Jay Wieczorek, Zachary Fellows, Vibha Chaswal, Vivek Mishra, Michael McDermott, Minesh Mehta, Alonso Gutierrez, and Ranjini Tolakanahalli

Dosimetric Comparison of GammaTile® Implants to Stereotactic Radiotherapy for Recurrent Brain Metastasis Resection Cavities., Robert Herrera, Rupesh Kotecha, D Jay Wieczorek, Zachary Fellows, Vibha Chaswal, Vivek Mishra, Michael McDermott, Vitaly Siomin, Minesh Mehta, Alonso Gutierrez, and Ranjini Tolakanahalli

Negative Predictive Value of Circulating Tumor Tissue Modified Viral (TTMV)-HPV DNA for HPV-driven Oropharyngeal Cancer Surveillance, Noah Kalman and Sreenija Yarlagadda

Advancing Beyond the Hippocampus to Improve Cognition for Patients with Brain Metastases: An Initial Report of a Phase 2 Trial Examining Memory-Avoidance Whole Brain Radiotherapy, Rupesh Kotecha

A randomized phase 2 trial of encorafenib + binimetinib + nivolumab vs ipilimumab + nivolumab in BRAFV600-mutant melanoma brain metastases: SWOG S2000 (NCT# 04511013). 2023 American Society of Clinical Oncology, Rupesh Kotecha

Clinical trial implementation: a primer for neurosurgeons, Rupesh Kotecha

Evaluating the diagnostic performance of 18F-fluciclovine for detection of recurrent brain metastases after radiation therapy: Results from a prospective phase 2 trial. 2023, Rupesh Kotecha

PDF

ISRS Technical Guidelines for Stereotactic Radiosurgery: Treatment of Small Brain Metastases (≤1 cm in diameter), Rupesh Kotecha

Phase I Dose Escalation Trial Combining Olaparib and Thoracic Radiation Therapy in Extensive-Stage Small Cell Lung Cancer, Rupesh Kotecha

PURSUE: results from a prospective, phase 2b trial to define image interpretation criteria for 18F-fluciclovine-PET for detection of recurrent brain metastases after radiation therapy, Rupesh Kotecha

Single-fraction radiosurgery outcomes for large vestibular schwannomas in the upfront or post-surgical setting: a systematic review and International Stereotactic Radiosurgery Society (ISRS) Practice Guidelines, Rupesh Kotecha

Tumor Treating Fields (TTFields) therapy with standard of care (SOC) systemic therapy in advanced non-small cell lung cancer (aNSCLC) following platinum failure: Final results of the phase 3, randomized LUNAR study, Rupesh Kotecha

Outcomes of MR-guided Stereotactic Body Radiotherapy (MRgSBRT) for adrenal metastases: A multi-institutional pooled analysis, Rupesh Kotecha and Tugce Kutuk

Evaluation of an interactive, multi-language, neurocognitive app in CNS radiation oncology, Rupesh Kotecha, Tugce Kutuk, Muni Rubens, Yazmin Odia, Matthew Hall, Michael McDermott, Manmeet Ahluwalia, Minesh Mehta, Suyen Ramos, and Miguel Ramirez Menendez

PDF

Evaluating the intracranial activity of adagrasib, Rupesh Kotecha, Alonso La Rosa de los Rios, Tugce Kutuk, Manmeet Ahluwalia, and Minesh Mehta

Surgically Targeted Radiation Therapy (STaRT) for brain metastases: Initial Experience from a Prospective Multi-institutional Registry, Rupesh Kotecha and Michael McDermott

PDF

Modern Meningioma Methods: Molecular Diagnostics and High Dose Protons, Rupesh Kotecha and Minesh Mehta

PDF

Rethinking classification and categorization of resection extent and its impact on patient survival in glioblastoma: Was Walter Dandy ahead of his time?, Rupesh Kotecha and Minesh Mehta

PDF

Key Clinical Principles in the Management of Glioblastoma, Rupesh Kotecha, Yazmin Odia, Atulya Khosla, and Manmeet Ahluwalia

Proton craniospinal irradiation for patients with solid tumor leptomeningeal metastasis: Initial real-world clinical experience, Tugce Kutuk, Haley Appel, Zachary Fellows, Alonso La Rosa de los Rios, Yazmin Odia, Matthew Hall, Manmeet Ahluwalia, Minesh Mehta, Rupesh Kotecha, and Sreenija Yarlagadda

Toxicity outcomes of dose-escalated MR-guided radiation therapy for abdominal and pelvic tumors, Tugce Kutuk, Michael Chuong, Kathryn Mittauer, Jessika Contreras, Adeel Kaiser, Matthew Hall, James McCulloch, Diane Alvarez, Minesh Mehta, Alonso Gutierrez, Rupesh Kotecha, Martin Tom, and Robert Herrera

The Initial Clinical Experience with an Interactive, Multi-Language, App-Based Neurocognitive Evaluation Program for Proton Therapy on CNS Malignancies, Tugce Kutuk, Rupesh Kotecha, Yazmin Odia, Matthew Hall, Haley Appel, Miguel Ramirez Menendez, Manmeet Ahluwalia, Minesh Mehta, and Alonso La Rosa de los Rios

Integration of an APP-based Neurocognitive Evaluation Program into Stereotactic Radiosurgery Practice: Outcomes and Patient Survey Analysis from a Prospective Observational Study, Tugce Kutuk, Cecilia Lee, Yazmin Odia, Alonso La Rosa de los Rios, Matthew Hall, Haley Appel, Michael McDermott, Manmeet Ahluwalia, Minesh Mehta, and Rupesh Kotecha

Implementation of an Interactive, Multi-Language, App-Based Neurocognitive Evaluation Program into Routine Stereotactic Radiosurgery Practice, Tugce Kutuk, Yazmin Odia, Matthew Hall, Haley Appel, Miguel Ramirez Menendez, Alexander Mohler, Michael McDermott, Manmeet Ahluwalia, Minesh Mehta, and Rupesh Kotecha

Surgically Targeted Radiation Therapy (STaRT) For Recurrent Brain Metastases: Initial Clinical Experience, Tugce Kutuk, Ranjini Tolakanahalli, D Jay Wieczorek, Haley Appel, Alonso Gutierrez, Alonso La Rosa de los Rios, Robert Herrera, Michael McDermott, Vitaly Siomin, Minesh Mehta, and Rupesh Kotecha

A comparative evaluation of different radiosurgery management strategies for large brain metastases: What is the optimal treatment paradigm?, Tugce Kutuk, Sreenija Yarlagadda, Ranjini Tolakanahalli, Matthew Hall, Anshul Saxena, Alonso La Rosa de los Rios, Martin Tom, D Jay Wieczorek, Cecilia Lee, Haley Appel, Michael McDermott, Manmeet Ahluwalia, Alonso Gutierrez, Minesh Mehta, Rupesh Kotecha, and Mukesh Roy

Characterization of Large Brain Metastases with 18F-Fluciclovine PET/CT Treated with Staged Stereotactic Radiosurgery (SSRS): Phase 1 Proof-of-Concept Interim Analysis, Alonso La Rosa de los Rios, Surya Chundru, Martin Tom, Tugce Kutuk, D Jay Wieczorek, Muni Rubens, Ranjini Tolakanahalli, Michael McDermott, Matthew Hall, Alonso Gutierrez, Manmeet Ahluwalia, Minesh Mehta, and Rupesh Kotecha

PDF

Temporally modulated pulsed proton re-irradiation (TMPPR) for recurrent high-grade gliomas, Alonso La Rosa de los Rios, Alonso Gutierrez, Yazmin Odia, Michael McDermott, Manmeet Ahluwalia, Minesh Mehta, and Rupesh Kotecha

Characterization of large brain metastases with 18F-Fluciclovine PET/CT treated with staged stereotactic radiosurgery (SSRS): interim analysis of a pilot study, Alonso La Rosa de los Rios, Tugce Kutuk, D Jay Wieczorek, Cecilia Lee, Ranjini Tolakanahalli, Michael McDermott, Matthew Hall, Alonso Gutierrez, Manmeet Ahluwalia, Rupesh Kotecha, and Minesh Mehta

PDF

Accelerated hypofractionated magnetic resonance-guided adaptive radiotherapy for oligoprogressive non-small cell lung cancer, Alonso La Rosa de los Rios, Kathryn Mittauer, Michael Chuong, Matthew Hall, Tugce Kutuk, Nema Bassiri-Gharb, James McCulloch, Diane Alvarez, Raul Herrera, Alonso Gutierrez, Ranjini Tolakanahalli, Minesh Mehta, and Rupesh Kotecha

PDF

Implementation of superficial radiation therapy (SRT) using SRT-100 Vision™ for non-melanoma skin cancer in a Radiation Oncology clinic, Cecilia Lee, Stephan Davis, William Romaguera, Vibha Chaswal, Ranjini Tolakanahalli, Alonso Gutierrez, and Noah Kalman

"Multi-institutional Experience of Definitive Proton Therapy for Osteosarcoma Acute Toxicities and Outcomes", Keitrina Mair, Katherine Von Werne, Noah Kalman, Michael Chuong, Matthew Hall, and Robert Press

Estimated Prevalence, Tumor Spectrum, and Neurofibromatosis Type 1-Like Phenotype of CDKN2A-Related Melanoma-Astrocytoma Syndrome, Arelis Martir-Negron and Yazmin Odia

A framework for standardised tissue sampling and processing during resection of diffuse intracranial glioma: joint recommendations from four RANO groups, Minesh Mehta

An Update on NRG Trials of Hippocampal Avoidance, Minesh Mehta

PDF

Benchmarking the Radiation Oncology Alternative Payment Model (RO-APM): Changes in Medicare Reimbursement for 16 Common Radiation Therapy Treatment Courses, Minesh Mehta

Depatuxizumab-mafodotin in EGFR-amplified newly diagnosed glioblastoma: a phase III randomized clinical trial, Minesh Mehta

Great Debates: Fractionated vs. Staged SRT for Brain Metastases, Minesh Mehta

Great Debates: Preopertavive vs. Postopertaive SRS for Brain Metastases, Minesh Mehta

How Does the Updated WHO Classification System of Gliomas Impact our Recommendations for Radiation Dose and Technology in 2023?, Minesh Mehta

Innovative Radiation Techniques, Minesh Mehta

Keynote: Future of Proton Therapy, Minesh Mehta

PDF

Low-risk meningioma: Initial outcomes from NRG Oncology/RTOG 0539, Minesh Mehta

Proton Therapy for CNS and Leptomeningeal Indications, Minesh Mehta

Radiosurgery for Gliomas, Minesh Mehta

Radiosurgery in Clinical Practice, Minesh Mehta

Radiosurgery: What are the Questions we Should be Asking?, Minesh Mehta

RANO 2.0: Update to the Response Assessment in Neuro-Oncology Criteria for High- and Low-Grade Gliomas in Adults, Minesh Mehta

SM: RANO 2.0: Proposal for an Update to the Response Assessment in Neuro-Oncology (RANO) Criteria for High- and Low-Grade Gliomas in Adults, Minesh Mehta

PDF

The Rationale for Radiation Therapy in Alzheimer's Disease, Minesh Mehta

Updates in CNS Malignancies, Minesh Mehta

A Multi-Institutional Phase 2 Trial of Ablative 5-Fraction Stereotactic Magnetic Resonance-Guided On-Table Adaptive Radiation Therapy for Borderline Resectable and Locally Advanced Pancreatic Cancer, Kathryn Mittauer and Michael Chuong

A Multi-Institutional Phase II Trial of Ablative 5-Fraction Stereotactic MR-Guided On-Table Adaptive Radiation Therapy for Borderline Resectable and Locally Advanced Pancreatic Cancer, Kathryn Mittauer and Michael Chuong

Initial Assessment of Adaptive Pancreas SBRT Treatment Efficiency using ViewRay MRIdian A3i, Kathryn Mittauer, Robert Herrera, James McCulloch, Diane Alvarez, Ranjini Tolakanahalli, Adeel Kaiser, Matthew Hall, Rupesh Kotecha, Minesh Mehta, Michael Chuong, and Nema Bassiri-Gharb

A novel multi-task hybrid deep neural network (DNN) predicts tumor progression during MRgRT, Kathryn Mittauer and Rupesh Kotecha

Online adaptive radiotherapy: Assessment of planning technique and its impact on longitudinal plan quality robustness in pancreatic cancer, Kathryn Mittauer, Sreenija Yarlagadda, John Bryant, Tino Romaguera, Andres Gomez, Robert Herrera, Rupesh Kotecha, Minesh Mehta, Alonso Gutierrez, and Michael Chuong

PDF

Radiation induced taste changes in head and neck cancer - differential impact of treatment factors, Tiffany Nong, Tammy Medrano, Muni Rubens, Adeel Kaiser, and Noah Kalman

Surgically Targeted Radiation Therapy (START) for Recurrent Glioblastoma: Initial Outcomes from a Prospective Multicenter Registry, Ahmad Ozair, Atulya Khosla, Rupesh Kotecha, Michael McDermott, and Manmeet Ahluwalia

PDF

DNA Methylation and Histone Modification in Low-Grade Gliomas: Current Understanding and Potential Clinical Targets, Ahmad Ozair, Atulya Khosla, Rupesh Kotecha, Yazmin Odia, Michael McDermott, and Manmeet Ahluwalia

PDF

Irreversible electroporation as a focal therapy for localized prostate cancer: A systematic review, Pushan Prabhakar, Arjun Pon Avudaiappan, Ahmed Eldefrawy, Jorge Caso, Govindarajan Narayanan, and Murugesan Manoharan